Tasimelteon
3 NDCs across 3 manufacturers|3 Generic,0 Brand
Tasimelteon is used to treat circadian rhythm sleep disorders, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Jan 31, 2014, and the first generic was approved Dec 12, 2022. FDA's Orange Book lists 4 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $98 million on Tasimelteon across 4,290 claims for 632 beneficiaries.
Tasimelteon is available as 3 NDCs from 3 manufacturers (3 generic, 0 brand), with NADAC prices from $228.25 to $228.25 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
3
3G / 0B
Manufacturers
3
competing in market
Price Spread
$228.25 – $228.25
per EA
7d Activity
avg -15.8% WoW · of 3 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Teva Pharmaceuticals USA Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Melatonin Receptor Agonist class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
3 manufacturers producing TASIMELTEON
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
TASIMELTEON 20 MG CAPSULE | $228.2480 per EA | -15.84% |
TASIMELTEON 20 MG CAPSULE | $228.2480 per EA | -15.84% |
TASIMELTEON 20 MG CAPSULE | $228.2480 per EA | -15.84% |
Frequently Asked Questions
What is Tasimelteon used to treat?
Tasimelteon is used to treat circadian rhythm sleep disorders, per the National Library of Medicine's MED-RT classification.
When did Tasimelteon become available as a generic?
FDA approved the first generic Tasimelteon (ANDA) on Dec 12, 2022. The Orange Book currently lists 4 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Tasimelteon?
In 2024, Medicare Part D spent $98 million on Tasimelteon across 4,290 claims for 632 beneficiaries.
How many Tasimelteon products are on the market?
The Tasimelteon drug market contains 3 NDCs from 3 manufacturers — 3 generic and 0 brand products.
What is the price range for Tasimelteon?
NADAC reference prices for Tasimelteon range from $228.2480 to $228.2480 per EA.
Which manufacturers make Tasimelteon?
3 manufacturers list Tasimelteon in NADAC. Ranked by number of NDCs, the largest are Teva Pharmaceuticals USA Inc. (1), Apotex Corp. (1), Amneal Pharmaceuticals NY LLC (1).
How has the price of Tasimelteon changed recently?
Over the past 7 days, 0 Tasimelteon NDCs rose and 3 fell, with a market-wide average change of -15.8%.